Lance U’Ren

856 total citations
16 papers, 561 citations indexed

About

Lance U’Ren is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Lance U’Ren has authored 16 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Lance U’Ren's work include Immunotherapy and Immune Responses (6 papers), Virus-based gene therapy research (5 papers) and Veterinary Oncology Research (5 papers). Lance U’Ren is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Virus-based gene therapy research (5 papers) and Veterinary Oncology Research (5 papers). Lance U’Ren collaborates with scholars based in United States, France and South Africa. Lance U’Ren's co-authors include Steven Dow, Robyn Elmslie, Douglas H. Thamm, Susan E. Lana, Daniel L. Gustafson, Susan Plaza, Paul S. Morley, Barbara J. Biller, Stephen J. Withrow and Marie E. Legare and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Lance U’Ren

15 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lance U’Ren United States	12	308	197	178	163	109	16	561
Beth Overley United States	13	433 1.4×	88 0.4×	223 1.3×	132 0.8×	77 0.7×	13	589
Matthew J. Atherton United States	14	314 1.0×	194 1.0×	285 1.6×	237 1.5×	142 1.3×	35	685
Keijiro Shiomitsu United States	10	225 0.7×	43 0.2×	70 0.4×	60 0.4×	63 0.6×	32	335
Barbara C. Rütgen Austria	14	308 1.0×	124 0.6×	138 0.8×	84 0.5×	126 1.2×	41	504
Erika Krick United States	15	538 1.7×	119 0.6×	218 1.2×	77 0.5×	59 0.5×	28	708
Sara D. Allstadt United States	12	319 1.0×	42 0.2×	174 1.0×	48 0.3×	53 0.5×	18	411
Catherine Ibisch France	10	171 0.6×	167 0.8×	62 0.3×	149 0.9×	65 0.6×	18	431
May Nouri United States	10	232 0.8×	107 0.5×	45 0.3×	89 0.5×	69 0.6×	12	528
Susan A. Kraegel United States	12	258 0.8×	31 0.2×	132 0.7×	114 0.7×	100 0.9×	18	409
Paola Laganga Italy	11	318 1.0×	57 0.3×	109 0.6×	54 0.3×	38 0.3×	18	399

Countries citing papers authored by Lance U’Ren

Since Specialization

Citations

This map shows the geographic impact of Lance U’Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lance U’Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lance U’Ren more than expected).

Fields of papers citing papers by Lance U’Ren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lance U’Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lance U’Ren. The network helps show where Lance U’Ren may publish in the future.

Co-authorship network of co-authors of Lance U’Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Lance U’Ren. A scholar is included among the top collaborators of Lance U’Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lance U’Ren. Lance U’Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Buuren, Nicholas van, Lance U’Ren, Kai Song, et al.. (2024). 184 Biomarker analysis of magrolimab plus docetaxel in patients with 2L+ mNSCLC from ELEVATE-Lung and UC, a phase 2 multicohort study. Regular and Young Investigator Award Abstracts. A212–A212. 1 indexed citations

2.

Kennedy, Laura C., Jun Lü, Arturo B. Ramirez, et al.. (2022). Liquid Biopsy Assessment of Circulating Tumor Cell PD-L1 and IRF-1 Expression in Patients with Advanced Solid Tumors Receiving Immune Checkpoint Inhibitor. Targeted Oncology. 17(3). 329–341. 3 indexed citations

3.

Kennedy, Laura C., Arturo B. Ramirez, Lance U’Ren, et al.. (2019). Circulating tumor cell (CTC) PD-L1 and interferon regulatory factor-1 (IRF-1) expression as biomarkers of anti-PD-(L)1 response.. Journal of Clinical Oncology. 37(15_suppl). e14032–e14032.

4.

Vossaert, Liesbeth, Qun Wang, Chunjing Qu, et al.. (2018). Reliable detection of subchromosomal deletions and duplications using cell‐based noninvasive prenatal testing. Prenatal Diagnosis. 38(13). 1069–1078. 31 indexed citations

5.

U’Ren, Lance, et al.. (2018). Abstract 5697: Simultaneous assessment of PD-L1 and IFR1 expression on breast cancer circulating tumor cells. Cancer Research. 78(13_Supplement). 5697–5697. 1 indexed citations

6.

Ramirez, Arturo B., Lance U’Ren, Daniel Campton, et al.. (2017). RareCyte® CTC Analysis Step 1: AccuCyte® Sample Preparation for the Comprehensive Recovery of Nucleated Cells from Whole Blood. Methods in molecular biology. 1634. 163–172. 16 indexed citations

7.

Young, Mary H., Lance U’Ren, Shouxiong Huang, et al.. (2013). MAIT Cell Recognition of MR1 on Bacterially Infected and Uninfected Cells. PLoS ONE. 8(1). e53789–e53789. 35 indexed citations

8.

Jordan, Kimberly R., et al.. (2012). Augmenting Antitumor T-Cell Responses to Mimotope Vaccination by Boosting with Native Tumor Antigens. Cancer Research. 73(1). 74–85. 16 indexed citations

9.

Sottnik, Joseph L., Lance U’Ren, Douglas H. Thamm, Stephen J. Withrow, & Steven Dow. (2009). Chronic bacterial osteomyelitis suppression of tumor growth requires innate immune responses. Cancer Immunology Immunotherapy. 59(3). 367–378. 40 indexed citations

10.

U’Ren, Lance, Amanda Guth, Debra A. Kamstock, & Steven Dow. (2009). Type I interferons inhibit the generation of tumor-associated macrophages. Cancer Immunology Immunotherapy. 59(4). 587–598. 36 indexed citations

11.

U’Ren, Lance, Barbara J. Biller, Robyn Elmslie, Douglas H. Thamm, & Steven Dow. (2007). Evaluation of a Novel Tumor Vaccine in Dogs with Hemangiosarcoma. Journal of Veterinary Internal Medicine. 21(1). 113–120. 54 indexed citations

12.

U’Ren, Lance, Barbara J. Biller, Robyn Elmslie, Douglas H. Thamm, & Steven Dow. (2007). Evaluation of a Novel Tumor Vaccine in Dogs with Hemangiosarcoma. Journal of Veterinary Internal Medicine. 21(1). 113–113. 56 indexed citations

13.

Lana, Susan E., Lance U’Ren, Susan Plaza, et al.. (2007). Continuous Low-Dose Oral Chemotherapy for Adjuvant Therapy of Splenic Hemangiosarcoma in Dogs. Journal of Veterinary Internal Medicine. 21(4). 764–769. 96 indexed citations

14.

Lana, Susan E., Lance U’Ren, Susan Plaza, et al.. (2007). Continuous Low-Dose Oral Chemotherapy for Adjuvant Therapy of Splenic Hemangiosarcoma in Dogs. Journal of Veterinary Internal Medicine. 21(4). 764–764. 95 indexed citations

15.

U’Ren, Lance, Ross M. Kedl, & Steven Dow. (2006). Vaccination with liposome–DNA complexes elicits enhanced antitumor immunity. Cancer Gene Therapy. 13(11). 1033–1044. 25 indexed citations

16.

U’Ren, Lance, et al.. (2004). Overexpression of the erbB-2 Proto-oncogene in Canine Osteosarcoma Cell Lines and Tumors. Veterinary Pathology. 41(3). 291–296. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact